Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-08-20 00:00:00 ET · period of report 2025-08-20 · accession 0001689325-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-20 | 2025-08-20 | ANIP | Pera Antonio R | Dir | S - Sale | $89.73 | -5,421 | 30.0K | -15% | -$486.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-20 | S | D | 5,421 | $89.73 | 29,952 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $89.27 to $90.18. The price reported above reflects the weighted average sales price. |